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Background 
Following the declaration of a state of emergency in the Commonwealth due to the 2019 novel 
Coronavirus (COVID-19) outbreak, MassHealth published All Provider Bulletin 289, introducing 
flexibilities for MassHealth coverage and billing necessitated by the COVID-19 outbreak. 
This bulletin supplements and, when specifically noted, modifies All Provider Bulletin 289 by 
providing additional flexibilities for coverage and billing related to COVID-19.  Unless specifically 
noted in this bulletin, providers should comply in all respects with All Provider Bulletin 289, which 
remains in full force and effect. 
This bulletin applies to members enrolled in MassHealth fee-for-service, the Primary Care Clinician 
(PCC) Plan, or a Primary Care ACO.  Information about coverage through MassHealth Managed 
Care Entities is included in MCE Bulletins 21 and 22. 
Program of All-Inclusive Care for the Elderly (PACE) organizations should follow the guidance set 
forth in this bulletin and in MCE Bulletins 21 and 22 when delivering services to MassHealth 
members. 
The Massachusetts Executive Office of Health and Human Services (EOHHS) is coordinating with 
federal and local partners to respond to COVID-19. As this situation evolves, EOHHS may issue 
additional guidance on this topic as informed and directed by the Massachusetts Department of 
Public Health (DPH) and the federal Centers for Disease Control and Prevention (CDC). 
As with All Provider Bulletin 289, this bulletin, and the flexibilities described herein, 
shall remain effective for the duration of the state of emergency declared via 
Executive Order No. 591.  Upon the expiration of that state of emergency, 
MassHealth will evaluate the continued need for each of the flexibilities that follow, 
and make appropriate adjustments, as necessary.
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Eligibility 
In order to enhance access to health care services during the COVID-19 outbreak, MassHealth is 
further expanding its Hospital-Determined Presumptive Eligibility (HPE) process to allow qualified 
hospitals to render HPE determinations for all individuals previously ineligible for HPE because 
they had received MassHealth benefits via HPE within the previous 12 months or had been enrolled 
in MassHealth Standard, MassHealth CommonHealth, MassHealth CarePlus, or MassHealth 
Family Assistance within the previous 12 months. This is an expansion of the policy announced in 
All Provider Bulletins 288 and 289, which allowed hospitals to render HPE determinations for 
previously ineligible individuals only if those individuals have a diagnosis or presumptive diagnosis 
of COVID-19.  Additional detail regarding this policy is available in All Provider Bulletin 290. 
Additional detail regarding MassHealth eligibility initiatives related to COVID-19 will appear in a 
forthcoming Eligibility Operations Memo. 
Billing for Covered Services Delivered via Telehealth 
Notwithstanding the statement to the contrary in Appendix A to All Provider Bulletin 289, an 
eligible distant site provider rendering covered services via telehealth in accordance with All 
Provider Bulletin 289 may bill MassHealth a facility fee if such a fee is permitted under such 
provider’s governing regulations or contracts.  For ease of reference, MassHealth has attached to 
this bulletin an amended Appendix A.  Providers rendering services via telehealth must continue 
to comply in all other respects with the telehealth-related section of All Provider Bulletin 289. 
Telehealth and the Prescription of Controlled Substances 
As described in All Provider Bulletin 289, MassHealth and MassHealth managed care entities 
permit qualified providers to deliver clinically appropriate, medically necessary MassHealth-
covered services to MassHealth members via telehealth (including telephone and live video) in 
accordance with the standards set forth in Amended Appendix A.  Pursuant to paragraph 1 of the 
"Additional Requirements for Prescribing" section of Amended Appendix A, providers who 
prescribe controlled substances through telehealth modalities should review the Department of 
Public Health’s “Alert Regarding Use of Telemedicine during Public Health Emergency-COVID-
19” and guidance from the Drug Enforcement Agency (DEA) concerning requirements for 
prescribing controlled substances via telehealth without an in-person visit, in addition to all 
other applicable state and federal statutes, regulations, and subregulatory guidance. 
Billing for COVID-19 Diagnostic Laboratory Services 
MassHealth-enrolled clinical laboratories and health care facilities should bill MassHealth for 
medically necessary, clinically appropriate COVID-19 lab tests using CPT code 87635, which 
describes infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe 
technique.  Providers will be able to bill MassHealth for this code beginning April 1, 2020, for dates 
of service on or after March 12, 2020. MassHealth will issue transmittal letters that formally add 
this code to the relevant provider manuals. MassHealth intends to pay a rate equal to the Medicare 
rate for this code. 
This is a limited modification of All Provider Bulletin 289, which directed providers to use a HCPCS 
code for medically necessary, clinically appropriate COVID-19 lab tests.  Aside from this limited 
modification, providers must continue to comply with all other requirements set forth in the “Billing 
for COVID-19 Diagnostic Laboratory Services” section of All Provider Bulletin 289. 
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For questions about testing, specimen transport, or control measures, contact the Massachusetts 
Department of Public Health (DPH) (24/7) at (617) 983-6800. Further information on testing can 
be found at DPH’s website. 
Pharmacy 
As described in greater detail in Pharmacy Facts Number 142, MassHealth is expanding the drug 
classes for which up to a 90-day supply may be dispensed.  Specifically, and notwithstanding the 
requirements of 130 CMR 406.411(D)(1): Days’ Supply Limitation, pharmacies may dispense up to a 
90-day supply of behavioral health medications and schedule IV benzodiazepines and hypnotics in 
quantities up to a 90 day supply, if requested by a MassHealth member or that member’s prescriber 
as long as sufficient quantity remains on the prescription to support the quantity being filled.  If, 
based on a pharmacist’s professional judgement, a pharmacy believes that dispensing up to a 90-
day supply of any drug not generally subject to this policy would be in the best interest of a 
MassHealth member, it may call the MassHealth Drug Utilization Review (DUR) program at (800) 
745-7318 to request an override. 
Furthermore, pharmacies should take all necessary steps to allow patients to maintain proper social 
distancing and minimize contact with objects touched by other individuals.  In particular, and 
notwithstanding any MassHealth or MassHealth managed care entity requirements to the contrary, 
pharmacies may not require a signature from a MassHealth member upon prescription drug pickup 
or delivery.  In addition, pharmacies are encouraged and allowed to provide prescription drugs to 
MassHealth members via curbside pickup, courier home delivery, or delivery by mail or other 
similar parcel delivery. 
Additionally, MassHealth is working to identify and extend prior authorizations (PA) for drugs that 
are due to expire in the coming weeks. MassHealth anticipates that these existing prior 
authorizations will be extended for another 60 days from the date of expiration. MassHealth is also 
removing PA requirements for certain drugs, allowing for emergency overrides if a claim is rejected 
for lack of PA, allowing for clozapine refills if current lab results cannot be obtained, and removing 
the requirement to use brand name ProAir when dispensing an albuterol inhaler. 
Finally, as described in greater detail in Pharmacy Facts Number 143, MassHealth is adopting new 
policies concerning the prescribing and dispensing of chloroquine and hydroxychloroquine.  
Pharmacy claims for chloroquine and hydroxychloroquine should process without a new prior 
authorization for individuals with existing prescriptions for lupus, malaria, or rheumatic conditions. 
If a rejection is encountered, please contact the Drug Utilization Review (DUR) program at 1-800-
745-7318 for further information. Consistent with All Provider Bulletin 289, in such circumstances 
pharmacies may dispense up to a 90-day supply if requested by a MassHealth member, or a 
prescriber, as long as sufficient quantity remains on the prescription to support the quantity being 
filled.  
Individuals who have or are suspected to have COVID-19 or who have new prescriptions for lupus, 
malaria, or rheumatic conditions must go through a prior authorization process before chloroquine 
and hydroxychloroquine can be dispensed. If a MassHealth member is approved for a diagnosis of 
COVID-19, pharmacies must dispense up to a 14-day supply.  If a MassHealth member is approved 
for other diagnoses, pharmacies may dispense up to a 90-day supply if requested by the MassHealth 
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member or a prescriber, as long as sufficient quantity remains on the prescription to support the 
quantity being filled. 
Prescribers may submit for prior authorization for chloroquine and hydroxychloroquine using the 
General Drug Prior Authorization Request form. 
Flexibility to Allow Opioid Treatment Programs and Acute Treatment Service 
Programs to Utilize Pharmacists to Dispense Certain Medication-Assisted 
Treatment 
In accordance with the March 18, 2020 Order of the Commissioner of Public Health 
Regarding the Treatment of Certain Medications for the Treatment of Opioid Use 
Disorder (Order), and notwithstanding any MassHealth requirement to the contrary, including 130 
CMR 418.405(A)(1)(a), MassHealth will allow reimbursement for appropriately licensed opioid 
treatment programs and acute treatment service providers who utilize pharmacists and pharmacy 
interns licensed by the Massachusetts Board of Registration in Pharmacy and in good standing to 
administer buprenorphine and methadone for the treatment of opioid use disorder in connection 
with the provision of covered services.  Opioid treatment programs and acute treatment service 
providers utilizing pharmacists and pharmacy interns to administer those medications must comply 
in all respects with the Order and all other applicable laws, regulations, and subregulatory guidance. 
Emergency Services Program (ESP) and Mobile Crisis Intervention (MCI) 
Services 
It is critical that MassHealth members continue to have access to behavioral health crisis 
assessment, intervention, and stabilization in acute outpatient hospital (AOH) emergency 
departments (EDs) and in the community during the COVID-19 emergency.  To the fullest extent 
possible, Emergency Service Program (ESP) and Mobile Crisis Intervention (MCI) providers 
should continue to ensure that services are delivered primarily in community settings and not in 
EDs. 
When a member presents to an ED with a behavioral health crisis, AOHs should contact the local 
ESP/MCI provider to deliver ESP/MCI services in the ED in accordance with current practice 
specifications.  There may be circumstances when the ESP/MCI providers may be unable to 
respond to MassHealth members in AOH EDs due to the COVID-19 emergency (e.g., limitations 
in ESP/MCI staffing or because AOH EDs are limiting access for purposes of infection control). 
Where ESP/MCI providers cannot respond to MassHealth members in the ED in person, 
ESP/MCI providers should provide ESP/MCI services using telehealth modalities in accordance 
with MassHealth All Provider Bulletin 289.    
To the extent that ESP/MCI providers cannot respond to MassHealth members in the ED either 
in person or using telehealth modalities, to ensure that members continue to have access to these 
services, AOHs with the capacity to have a qualified behavioral health professional (master or 
doctoral level behavioral health clinician, psychiatric nurse practitioner, psychiatric clinical nurse 
specialist, or psychiatrist) provide behavioral health crisis assessment, intervention, and 
stabilization may provide these services in lieu of an ESP/MCI provider. Children and 
adolescents should be evaluated by a child-trained qualified behavioral health professional. If a 
child-trained clinician is unavailable, an adult-trained clinician should perform the evaluation 
with consultation or supervision from a child-trained clinician wherever possible.  Such 
consultation or supervision may be conducted using telehealth modalities.
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The AOH is responsible for the member’s treatment planning and follow-up clinical care, 
inclusive of bed finding for 24-hour levels of care. AOHs must also verify member MassHealth 
eligibility and complete any required managed care service authorization procedures. 
The ESP/MCI providers continue to be responsible for community-based follow up as required 
by their contract, with the added flexibility of the telehealth modalities (including telephone)  
found in All Provider Bulletin 289.  If a youth is discharged to follow-up care, the Emergency 
Department must contact the local MCI provider to ensure community-based stabilization can be 
provided. 
AOHs rendering these behavioral health crisis services pursuant to this flexibility should bill 
MassHealth using the HCPCS Level II code S9485. MassHealth will issue a transmittal letter that 
formally adds this code to the Acute Outpatient Hospital manual.  MassHealth will pay for this 
code using the rate set by EOHHS in 101 CMR 306.00:  Rates of Payment for Mental Health 
Services Provided in Community Health Centers and Mental Health Centers.  
MCI programs providing 7-day follow-up care to youth evaluated in hospital Emergency 
Departments should continue to bill MassHealth using the following codes: 
• H2011-U1 Crisis intervention service, per 15 minutes. Youth Mobile Crisis intervention modifier 
for service provided by a Master Level Clinician (used with H2011 only) 
• H2011-U2 Crisis intervention services, per 15 minutes. Youth Mobile Crisis intervention 
modifier for service provided by a paraprofessional (used with H2011 only) 
 
Primary Care Clinician Plan & Primary Care ACO Referrals  
Notwithstanding the requirements of 130 CMR 450.118(J) and 130 CMR 450.119(I), members 
enrolled in the Primary Care Clinician (PCC) Plan or a Primary Care ACO do not need a referral to 
receive any MassHealth covered service that would otherwise require a referral.  This is an 
expansion of the policy announced in All Provider Bulletin 289. 
Admission to Chronic Disease and Rehabilitation Hospitals 
Notwithstanding 130 CMR 435.408: Screening Program for Chronic-Disease and Rehabilitation 
Hospitals, MassHealth will not require pre-admission screening of individuals seeking admission 
to Chronic Disease and Rehabilitation Hospitals (CDRH). Instead, a CDRH may admit a member 
after submitting a notification of admission packet to MassHealth, with specific additional 
documentation. The admission will be subject to concurrent and retrospective review as clinically 
indicated. The requirements for this submission will be more fully described in forthcoming 
guidance from the Office of Long-term Services and Supports.  
Signatures for Transportation Medical Necessity Forms 
In order to maintain social distancing and promote contactless transactions, and notwithstanding 
130 CMR 407.421(D)(2), transportation providers should not require authorized providers or 
managed-care representatives to provide physical signatures on Medical Necessity Forms.  Instead, 
transportation providers should enter “Signature not provided related to COVID-19” in the relevant 
signature fields of those forms.
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Billing Code for Transportation Providers Obtaining Specimens for COVID-19 
Diagnostic Testing Without Member Transportation 
Notwithstanding any regulation to the contrary, including the definition of "Trip" under 101 CMR 
327.00 and  130 CMR 407.411(A)'s restriction on coverage for transportation services to 
situations in which a member is travelling to obtain medical services, MassHealth will reimburse 
transportation providers for medically necessary visits to members to obtain and transport 
specimens for COVID-19 diagnostic testing through HCPCS code A0998 (Ambulance response 
and treatment; no transport) for dates of service on or after April 1, 2020.  MassHealth will issue 
a transmittal letter that formally adds this code to the Transportation Manual. Simultaneously, 
EOHHS intends to issue an Administrative Bulletin that will formally add this code to 101 CMR 
327.00:  Rates of Payment for Ambulance and Wheelchair Van Services.  MassHealth will pay 
this code at the rate set by EOHHS, which MassHealth anticipates to be $157.88. 
Transportation providers may not bill MassHealth for mileage in connection with services billed 
through this code. 
Additional Information 
For the latest Massachusetts-specific information, visit the following link: 
https://www.mass.gov/resource/information-on-the-outbreak-of-coronavirus-disease-2019-covid-
19. 
The latest Centers for Disease Control and Prevention (CDC) guidance for healthcare professionals 
is available at the following link: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html. 
MassHealth Website 
This bulletin is available on the MassHealth Provider Bulletins web page. 
To sign up to receive email alerts when MassHealth issues new bulletins and transmittal letters, 
send a blank email to join-masshealth-provider-pubs@listserv.state.ma.us. No text in the body or 
subject line is needed.  
Questions 
If you have any questions about the information in this bulletin, please contact the MassHealth 
Customer Service Center at (800) 841-2900, email your inquiry to providersupport@mahealth.net, 
or fax your inquiry to (617) 988-8974. 
  
 Amended Appendix A 
Guidelines for Use of Telehealth to Deliver Covered Services 
Terminology 
For the purposes of this bulletin, the following terms are used as defined below. 
Distant site is the site where the practitioner providing the service is located at the time the service 
is provided. While all applicable licensure and programmatic requirements apply to the delivery of 
the service, there are no additional geographic or facility restrictions on distant sites for services 
delivered via telehealth. 
Originating site is the location of the member at the time the service is being provided. There are 
no geographic or facility restrictions on originating sites.  
Billing and Payment Rates for Services  
Providers must include the Place of Service (POS) Code 02 when submitting a claim for services 
delivered via telehealth. Rates of payment for services delivered via telehealth will be the same as 
rates of payment for services delivered via traditional (e.g., in-person) methods set forth in the 
applicable regulations. 
Providers may not bill MassHealth a facility fee for originating sites. 
Additional Requirements for Prescribing 
A provider may prescribe medications via telehealth as otherwise described in this bulletin and in 
accordance with the following requirements. 
1. Providers must comply with all applicable state and federal statutes and regulations governing 
medication management and prescribing services when delivering these services via telehealth. 
2. Providers who deliver prescribing services via telehealth must maintain policies for providing 
patients with timely and accurate prescriptions by use of mail, phone, e-prescribing and/or fax. 
Providers must document prescriptions in the patient’s medical record consistent with in-person 
care. 
 
Requirements for Telehealth Encounters 
Providers must adhere to and document the following best practices when delivering services via 
telehealth. 
1. Providers must properly identify the patient using, at a minimum, the patient’s name, date of 
birth, and MassHealth ID. 
2. Providers must disclose and validate the provider’s identity and credentials, such as the 
provider’s license, title, and, if applicable, specialty and board certifications. 
3. For an initial appointment with a new patient, the provider must review the patient’s relevant 
medical history and any available medical records with the patient before initiating the delivery of 
the service. 
 4. For existing provider-patient relationships, the provider must review the patient’s medical history 
and any available medical records with the patient during the service. 
5. Prior to each patient appointment, the provider must ensure that the provider is able to deliver 
the service to the same standard of care and in compliance with licensure regulations and 
requirements, programmatic regulations, and performance specifications related to the service (e.g., 
accessibility and communication access) using telehealth as is applicable to the delivery of the 
services in person. If the provider cannot meet this standard of care or other requirements, the 
provider must direct the patient to seek in-person care. The provider must make this determination 
prior to the delivery of each service. 
6. To the extent feasible, providers must ensure the same rights to confidentiality and security as 
provided in face-to-face services.  Providers must inform members of any relevant privacy 
considerations. 
7. Providers must follow consent and patient information protocol consistent with those followed 
during in person visits. 
8. Providers must inform patients of the location of the provider rendering services via telehealth 
(i.e., distant site) and obtain the location of the patient (i.e., originating site). 
9. The provider must inform the patient of how the patient can see a clinician in-person in the event 
of an emergency or as otherwise needed. 
Documentation and Record Keeping 
Providers delivering services via telehealth must meet all health records standards required by the 
applicable licensing body as well as any applicable regulatory and program specifications required 
by MassHealth. This includes storage, access, and disposal of records.  
In addition to complying with all applicable MassHealth regulations pertaining to documentation of 
services, providers must include a notation in the medical record that indicates that the service was 
provided via telehealth, the technology used, and the physical location of the distant and the 
originating sites. The provider must also include the CPT code for the service rendered via 
telehealth in the patient’s medical record. 
MassHealth may audit provider records for compliance with all regulatory requirements, including 
record keeping and documentation requirements, and may apply appropriate sanctions to providers 
who fail to comply. 
 
 
